LATE BREAKING ABSTRACT: Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patient...

Date 27 September 2015
Event European Cancer Congress 2015
Session Immunotherapy in Cancer I
Topics Cancer Immunology and Immunotherapy
Presenter Rini, B.